Li, Hongmei

Low dose zymosan ameliorates both chronic and relapsing experimental autoimmune encephalomyelitis. [electronic resource] - Journal of neuroimmunology Jan 2013 - 28-38 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural

1872-8421

10.1016/j.jneuroim.2012.08.013 doi


Adoptive Transfer--methods
Animals
Anti-Inflammatory Agents, Non-Steroidal--therapeutic use
Antigens, CD--metabolism
Butadienes--pharmacology
CD4-Positive T-Lymphocytes--drug effects
Cell Differentiation--drug effects
Cell Line, Transformed
Chronic Disease
Coculture Techniques
Cytokines--metabolism
Dose-Response Relationship, Drug
Encephalomyelitis, Autoimmune, Experimental--drug therapy
Enzyme Inhibitors--pharmacology
Female
Flow Cytometry
Gene Expression--immunology
Interferon-alpha--pharmacology
Lipopolysaccharides--pharmacology
Macrophages--drug effects
Mice
Mice, Inbred Strains
Mice, Transgenic
Microglia--drug effects
Myelin Proteolipid Protein--immunology
Myelin-Oligodendrocyte Glycoprotein--immunology
Nitriles--pharmacology
Peptide Fragments--immunology
Receptors, Antigen, T-Cell--genetics
Secondary Prevention
Severity of Illness Index
T-Lymphocytes, Regulatory--drug effects
Time Factors
Tritium
Zymosan--therapeutic use